603168.SHG Zhejiang Shapuaisi Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
5.12 CNY
Close of Nov 4, 2026
4.55 8.81
Market cap
CNY 1.91B
P/E
-
P/B
1.47x
ROE
-6.8%
Dividend yield
0.42%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603168.SHG undervalued?

Graham number

The Graham number of Zhejiang Shapuaisi Pharmaceutical Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Zhejiang Shapuaisi Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Zhejiang Shapuaisi Pharmaceutical Co Ltd yet.

Zhejiang Shapuaisi Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Zhejiang Shapuaisi Pharmaceutical Co Ltd

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. It also offers medical and health care, and scientific research and teaching facilities. Zhejiang …

Full company profile